Monday, May 5, 2025

COVID-19: Nigeria receives 100,000 doses of Covishield vaccines donated by India

Must read

- Advertisement -
tiamin rice
tiamin rice

The federal government says it has received 100,000 doses of Covishield vaccines donated by the Indian government.

The chairman of the Presidential Task Force, PTF on COVID-19 and Secretary to the Government of the Federation, Boss Mustapha, confirmed this on Tuesday at the national briefing by the PTF.

HE said, “As you are aware, Nigeria received 3.94 million doses of the COVID-19 Oxford/AstraZeneca vaccine on March 2, 2021.

tiamin rice

“These vaccines represented the first tranche of about 16 million doses allocated to Nigeria through the COVAX facility, aimed at vaccinating an initial 20 percent of the population.

“More vaccines are also expected from the African Union’s Vaccine Acquisition Task Team (AVATT).

READ ALSO:   Emefiele: Rights organisation cautions against interference in SSS investigations

“We shall also be receiving about 100,000 doses of Covishield vaccines donated by the Government of India to Nigeria. This will further boost the number of Nigerians to be vaccinated by about 50,000.

whatsApp

“The PTF through the Federal Ministry of Health (FMoH) and the National Primary Health Center Development Agency (NPHCDA) prioritised the initial consignment of vaccines to cover frontline medical personnel, strategic leadership, and those above the age of 50 years across the nation.

“Majority of sub-national entities have already received their allocation and administration is progressing.

“As at April 5, 2021, 963,802 persons in Nigeria had received the first dose of the COVID-19 vaccine.

READ ALSO:    Save-and-Win draws: Polaris bank gives away N26m to 188 Nigerians

“The overarching objective is to vaccinate 70 percent of Nigeria’s population between 2021 and 2022.”

The News Agency of Nigeria reports that the vaccine was presented to the PTF by the acting Indian High Commissioner to Nigeria, Mr Velagaleti Surendra.

NAN

- Advertisement -

More articles

- Advertisement -

Latest article

- Advertisement -